Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes-Reference-Cited by-全球学者库

Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes

Published:2023-01-02 Issue:1 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Zhou Xiaoying¹,Lu Huixia²,Sang Miaomiao¹,Qiu Shanhu³,Yuan Yang¹,Wu Tongzhi⁴,Chen Junhao⁵,Sun Zilin¹

Affiliation:

1. Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing, China

2. Department of Clinical Laboratory Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China

3. Department of General Practice, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing, China

4. Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, Australia

5. Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China

Funder

National Key R&D Program of China

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2184754

Reference47 articles.

1. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes

2. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

3. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

4. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19

5. WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study);BMJ Open Diabetes Research & Care;2024-01

2. Incidence of SARS-CoV-2 infection in children shortly after ending zero-COVID-19 policy in China on December 7, 2022: a cross-sectional, multicenter, seroepidemiological study;Frontiers in Public Health;2023-11-09

3. Adverse Effects Reported and Insights Following Sinopharm COVID-19 Vaccination;Current Microbiology;2023-10-20

4. Uncoupling of the center-to-periphery arterial stiffness gradient and pulse pressure amplification in viral pneumonia infection;BMC Infectious Diseases;2023-10-05